Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gaba Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Gaba Therapeutics

Gaba Therapeutics

Series A

GABA Therapeutics: Pioneering fast, safe, non-addictive anxiety and depression solutions with GRX-917.

HQ
Delaware, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

GABA Therapeutics was founded with the core mission of developing innovative treatments for anxiety, depression, and chronic pain that are fast-acting, safe, and non-addictive. The company’s flagship product, GRX-917, leverages the production of endogenous neurosteroids and inhibits NLRP3 inflammation to offer a transformative solution for neuropsychiatric, neurological, and autoimmune disorders. GABA Therapeutics aims to address the unmet needs in mental health treatment with minimal side effects and no addiction potential.

Notable figures affiliated with GABA Therapeutics include Richard Farrell. The company has achieved significant milestones, including preparing GRX-917 for Phase 3 registration studies in anxiety. By focusing on mechanisms that induce natural neurosteroid production, GABA Therapeutics has made a substantial impact in the field of mental health, offering hope for safer and more effective treatments for anxiety and depression.

Gaba Therapeutics - Similar Companies

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Gain Therapeutics logo

Gain Therapeutics

Neurogastrx logo

Neurogastrx

neurogastrx.com

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Zena Therapeutics logo

Zena Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Neuronascent logo

Neuronascent

neuronascent.com

Libra Therapeutics logo

Libra Therapeutics

Evecxia logo

Evecxia

evecxia.com

Neuraly logo

Neuraly

neuralymed.com

Delix Therapeutics logo

Delix Therapeutics

GlobeStar Therapeutics logo

GlobeStar Therapeutics

NeyroblastGX logo

NeyroblastGX

neyroblastgx.com

Therini Bio logo

Therini Bio

therinibio.com

Gaba Therapeutics - Quick Facts

Who are Gaba Therapeutics' competitors?

Companies similar to Gaba Therapeutics include Psy Therapeutics, Gain Therapeutics, Neurogastrx and NeuroTherapia.

When was Gaba Therapeutics founded?

Gaba Therapeutics was founded in 2018.

Where is Gaba Therapeutics' headquarters located?

Gaba Therapeutics' headquarters is located in Delaware, US.

When was Gaba Therapeutics' last funding round?

Gaba Therapeutics' most recent funding round was for $15.5M (USD) in September 2019.

How much has Gaba Therapeutics raised to-date?

As of Sep 23, 2019, Gaba Therapeutics has raised a total of $15.5M (USD).

How many employees does Gaba Therapeutics have?

Gaba Therapeutics has 35 employees as of Feb 5, 2024.

Gaba Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified